Switzerland· 69761003
Vueway, Soluzione iniettabile
A gadopiclenol product containing gadopiclenolum, registered in Switzerland by Bracco Suisse SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Gadopiclenol is registered in 13 of 19 countries.
Countries holding a registration under ATC V08CA12 (gadopiclenol), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Gadopiclenol · ATC V08CA12
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- gadopiclenolum
- Manufacturer
- Bracco Suisse SA
- Country
- Switzerland (CH)
- ATC code
- V08CA12
- ATC class
- Gadopiclenol
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680697610039Durchstf 1 StkCHF 106.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gadopiclenol in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaELUCIREMGuerbet, Roissy CdG Cedex
- BelgiumElucirem 0.5 mmol/mlGuerbet
- SpainELUCIREM 0,5 MMOL/ML SOLUCION INYECTABLEGuerbet
- PolandEluciremGuerbet
- SwedenElucirem 0,5 mmol/ml Injektionsvätska, lösningGuerbet
- NorwayVuewayBracco Imaging SpA
- United StatesELUCIREMGuerbet LLC
- United KingdomElucirem 0.5mmol/ml solution for injection 10ml pre-filled syringesGuerbet Laboratories Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Elucirem
- Iceland · Elucirem
- Norway · Elucirem, Vueway
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5bb227b-490a-4d22-be52-c13f2a5215b1 GET /v1/drugs/d5bb227b-490a-4d22-be52-c13f2a5215b1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "gadopiclenolum 5 mmol",
"valid_from": "2025-05-01",
"limitations": "[{\"description\":\"VUEWAY wird in allen Indikationen ausschliesslich in einer Dosierung von 0.05 mmol/kg Körpergewicht entsprechend 0.1 mL/kg Körpergewicht vergütet.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2025-05-01\"}]",
"galenic_form": "Inj Lös 0.5 mmol/ml 10 ml Durchstechf",
"therapeutic_area": null,
"sl_inclusion_date": "2025-05-01",
"self_retention_pct": 10
}See everything about gadopiclenol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.